Cargando…
Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding
The main aims of therapy in chronic stable angina are to reduce the risk of myocardial infarction and death and improve symptoms and quality of life (QoL). Unblinded trials have shown that revascularization does not reduce the risk of myocardial infarction or death but does appear to improve symptom...
Autores principales: | Nowbar, Alexandra N, Francis, Darrel P, Al-Lamee, Rasha K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519715/ https://www.ncbi.nlm.nih.gov/pubmed/34417901 http://dx.doi.org/10.1007/s10557-021-07198-8 |
Ejemplares similares
-
Remote digital smart device follow-up in prospective clinical trials: early insights from ORBITA-2, ORBITA-COSMIC, and ORBITA-STAR
por: Ganesananthan, Sashiananthan, et al.
Publicado: (2022) -
Achieving Optimal Medical Therapy: Insights From the ORBITA Trial
por: Foley, Michael, et al.
Publicado: (2021) -
Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial
por: McCreanor, Victoria, et al.
Publicado: (2021) -
The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial
por: Hartley, Adam, et al.
Publicado: (2021) -
Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial( )
por: Ganesananthan, Sashiananthan, et al.
Publicado: (2022)